Evidence map›Paper›PMID 24426817›Full record

Trial reportJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2014

The effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidation.

Janine M Hall-Porter, Paula K Schweitzer, Rhody D Eisenstein, Hasan Ali H Ahmed, James K Walsh

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Dexmedetomidine promotes biomimetic non-rapid eye movement stage 3 sleep in humans: A pilot study.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2018
    Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. The Treatment of Sleep Dysfunction in Neurodegenerative Disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research.Perspectives on psychological science : a journal of the Association for Psychological Science · 2015
    Review
  15. Review
  16. Article
  17. Sleep for cognitive enhancement.Frontiers in systems neuroscience · 2014
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Janine M Hall-PorterSleep Medicine and Research Center, St. Luke's Hospital, Chesterfield, MO.
Paula K SchweitzerSleep Medicine and Research Center, St. Luke's Hospital, Chesterfield, MO.
Rhody D EisensteinSleep Medicine and Research Center, St. Luke's Hospital, Chesterfield, MO.
Hasan Ali H AhmedSleep Medicine and Research Center, St. Luke's Hospital, Chesterfield, MO.
James K WalshSleep Medicine and Research Center, St. Luke's Hospital, Chesterfield, MO.
St. Luke's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNumerous studies have demonstrated that sleep promotes memory consolidation, but there is little research on the effect of hypnotics on sleep-dependent memory consolidation. We compared bedtime administration of zolpidem-ER 12.5 mg (6- to 8-h duration of action), middle-of-the-night administration of zaleplon 10 mg (3- to 4-h duration of action), and placebo to examine the effect of different durations of hypnotic drug exposure on memory consolidation during sleep.

methodsTwenty-two participants with no sleep complaints underwent 3 conditions in a counterbalanced crossover study: (1) zolpidem-ER 12.5 mg (bedtime dosing), (2) zaleplon 10 mg (middle-of-the-night dosing), and (3) placebo. Memory testing was conducted before and after an 8-h sleep period, using a word pair association task (WPT; declarative memory) and a finger-tapping task (FTT; procedural memory).

resultsANOVA revealed a significant condition effect for the WPT (p = 0.025) and a trend for the FTT (p = 0.067), which was significant when sex was added to the model (p = 0.014). Improvement in memory performance following sleep was lower with bedtime dosing of zolpidem-ER compared to placebo and middle-of-the-night dosing of zaleplon. There were no differences between placebo and zaleplon.

conclusionsThe results suggest that in some circumstances hypnotics may have the potential to reduce the degree of sleep-dependent memory consolidation and that drug-free sleep early in the night may ameliorate this effect.

Indexed as

AcetamidesAdultCross-Over StudiesDouble-Blind MethodFemaleGABA-A Receptor AgonistsHumansHypnotics and SedativesMaleMemoryPsychomotor PerformancePyridinesPyrimidinesSex FactorsZolpidemAcetamidesGABA-A Receptor AgonistsHypnotics and SedativesPyridinesPyrimidineszaleplonZolpidemHypnoticsmemory consolidationsleep

Identifiers

PMID24426817
PMCPMC3869065
OpenAlexW2026434433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.